These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24416611)

  • 1. Catatonic dilemma in a 33-year-old woman: a discussion.
    Koch A; Reich K; Wielopolski J; Clepce M; Fischer M; Kornhuber J; Thuerauf N
    Case Rep Psychiatry; 2013; 2013():542303. PubMed ID: 24416611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute catatonic syndrome after neuroleptic malignant syndrome].
    Benjelloun G; Jehel L; Abgrall G; Pelissolo A; Allilaire J
    Encephale; 2005; 31(6 Pt 1):705-9. PubMed ID: 16462690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid symptom control in neuroleptic malignant syndrome with electroconvulsive therapy: A case report.
    Katzell L; Beydler E; Dos Santos AS; Vijayvargiya R; Carr BR
    Front Psychiatry; 2023; 14():1143407. PubMed ID: 37032940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.
    Huang MW; Gibson RC; Jayaram MB; Caroff SN
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013100. PubMed ID: 35844143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].
    Erol A; Putgül G; Sert E; Mete L
    Turk Psikiyatri Derg; 2013; 24(2):140-4. PubMed ID: 23754268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.
    Komatsu T; Nomura T; Takami H; Sakamoto S; Mizuno K; Sekii H; Hatta K; Sugita M
    Intern Med; 2016; 55(19):2893-2897. PubMed ID: 27725556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam.
    Yacoub A; Francis A
    Neuropsychiatr Dis Treat; 2006 Jun; 2(2):235-40. PubMed ID: 19412469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review.
    Chiou YJ; Lee Y; Lin CC; Huang TL
    Medicine (Baltimore); 2015 Oct; 94(43):e1752. PubMed ID: 26512569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ["Catatonic dilemma". Therapy with lorazepam and clozapine].
    Lausberg H; Hellweg R
    Nervenarzt; 1998 Sep; 69(9):818-22. PubMed ID: 9789276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
    Menard ML; Yagoubi F; Drici M; Lavrut T; Askenazy F
    Encephale; 2013 May; 39 Suppl 1():S29-35. PubMed ID: 23219595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Catatonia: resurgence of a concept. A review of the international literature].
    Pommepuy N; Januel D
    Encephale; 2002; 28(6 Pt 1):481-92. PubMed ID: 12506260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroconvulsive Therapy-Resistant Catatonia: Case Report and Literature Review.
    Hasoglu T; Francis A; Mormando C
    J Acad Consult Liaison Psychiatry; 2022; 63(6):607-618. PubMed ID: 35842127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity: a case report.
    Yeh AW; Lee JW; Cheng TC; Wen JK; Chen WH
    Clin Neuropharmacol; 2004; 27(5):216-8. PubMed ID: 15602101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
    Markianos M; Hatzimanolis J; Lykouras L
    Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECT for prolonged catatonia.
    Malur C; Pasol E; Francis A
    J ECT; 2001 Mar; 17(1):55-9. PubMed ID: 11281518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and treatment of neuroleptic malignant syndrome.
    Ebadi M; Pfeiffer RF; Murrin LC
    Gen Pharmacol; 1990; 21(4):367-86. PubMed ID: 1974219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual catatonic state following neuroleptic malignant syndrome.
    Caroff SN; Mann SC; Keck PE; Francis A
    J Clin Psychopharmacol; 2000 Apr; 20(2):257-9. PubMed ID: 10770467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Casamassima F; Litta A; Mauri M; Cassano GB
    Riv Psichiatr; 2012; 47(2):178-85. PubMed ID: 22622253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.